69318-23-6

Basic information

• Product Name: Phenol, 2-fluoro-6-(2-propenyl)- (9CI)
• Synonyms: Phenol, 2-fluoro-6-(2-propenyl)- (9CI)
• CAS NO: 69318-23-6
• Molecular Formula: C9H9FO
• Molecular Weight: 0
• Mol File: 69318-23-6.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Phenol, 2-fluoro-6-(2-propenyl)- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Phenol, 2-fluoro-6-(2-propenyl)- (9CI)(69318-23-6)
• EPA Substance Registry System: Phenol, 2-fluoro-6-(2-propenyl)- (9CI)(69318-23-6)

Safety Data

• Hazardous Substances Data: 69318-23-6(Hazardous Substances Data)

Upstream product

• 367-12-4 2-fluorophenol 
• 57264-49-0 1-(allyloxy)-2-fluorobenzene 
• 367-05-5 Sodium 2-fluorophenoxide 

Relevant articles and documents

Subsupercritical Water Generated by Inductive Heating Inside Flow Reactors Facilitates the Claisen Rearrangement

Claisen rearrangement of electron-deficient O-allylated phenols, including fluorine-modified phenols, is facilitated in aqueous media at high temperatures and pressures under flow conditions, as opposed to organic solvents. The O-allylation of phenols can be coupled with the Claisen rearrangement in an integrated flow system.

C- ARYL GLYCOSID DERIVATIVES, PHARMACEUTICAL COMPOSITION, PREPARATION PROCESS AND USES THEREOF

This invention relates to a kind of C-aryl glycoside derivatives, its pharmaceutical compositions, preparation methods, and uses thereof. The preparation method comprises: method 1: in a solvent, deprotecting the acetyl protecting groups of compound 1-f in the presence of a base; method 2: 1) compound 2-g reacts with via Mitsunobu reaction; 2) deprotecting the acetyl protecting groups of compound 2-f obtained from step 1; method 3: 1) compound 2-g reacts with via nucleophilic substitution reaction; 2) deprotecting the acetyl protecting groups of compound 3-f obtained from step 1. The pharmaceutical composition comprises a kind of C-aryl glycoside derivatives; it's pharmaceutically acceptable salts and/or prodrugs thereof and excipient thereof. This invention further relates to a kind of C-aryl glycoside derivatives, it's pharmaceutically acceptable salts or pharmaceutical compositions thereof for the use in preparation of a SGLT inhibitor. The C-aryl glycoside derivatives of this invention provides a new direction for the study of SGLT inhibitors.

2 - fluoro - 4 - allyl - 6 - nitro-phenol with 2 - fluoro - 4 - nitro - 6 - allyl phenol joint preparation and use

Disclosed are a combined preparation method and an application of 2-fluoro-4-allyl-6-nitrophenol and 2-fluoro-4-nitro-6-allyl phenol. The combined preparation method comprises the steps: with 2-fluorophenyl allyl ether as a raw material, carrying out Clai

Synthesis and pharmacological evaluation of 2-(1-alkylpiperidin-4-yl)-N- [(1R)-1-(4-fluorophenyl)-2-methylpropyl]acetamide derivatives as novel antihypertensive agents

We synthesized and evaluated the inhibitory activity of a series of 2-(1-alkylpiperidin-4-yl)-N-[(1R)-1-(4-fluorophenyl)-2-methylpropyl]acetamide derivatives against T-type Ca2+ channels. Structure-activity relationship studies revealed that th

IMPROVED PROCESS FOR THE PREPARATION OF HALO-DIALKOXYBENZENES

The invention describes an improved method for producing halo-dialkoxybenzenes of formula (I) such as 1-fluoro-2, 3-dialkoxybenzene as well as 2-fluoro-1, 4-dialkoxybenzene, Formula (I) by reacting commercial 2-fluorophenol is reacted with an allyl halide